Beijing Lansson Pharmaceutical Technology

Beijing Lansson Pharmaceutical Technology is a prominent Chinese pharmaceutical R&D company focused on the development of high-end generic drugs and innovative chemical entities. Established in 2004, the company provides a full suite of services ranging from drug discovery and formulation development to clinical trial coordination and technology transfer. Their therapeutic focus primarily encompasses cardiovascular, oncology, and metabolic disorders, with specialized expertise in complex formulations and consistency evaluations for generic medications. Lansson operates as both an independent developer and a strategic partner for major Chinese pharmaceutical firms, leveraging its advanced R&D platforms to bring cost-effective and high-quality medications to market. The company maintains a significant presence in the domestic market through its integrated R&D and manufacturing capabilities.